The Sept. 21 announcement states that Gadopiclenol Injection—a highly stable macrocyclic gadolinium-based contrast agent—is approved for use in adult and pediatric patients aged 2 years and older during MRI exams.

The acquisition represents a significant advance in interoperability and will combine networks that total over 80 billion images globally, including data from institutions such as Mayo Clinic, Cleveland Clinic and New York Presbyterian Hospital.

After experts from one institution evaluated 500 portable chest x-rays completed during the summer of 2021, it was revealed that 46.2% of the images obtained were problematic, requiring the imaging to be repeated. 

With the software’s help, the ratio of CTs requiring radiologist review to missed findings identified was 10:1, experts shared, adding that without the help of AI that ratio would be at least 66:1. 

Denoising using deep learning techniques can boost the performance of 1.5T MR brain imaging, resulting in quality comparable or superior to 3T imaging. 

In an effort to perhaps dissuade skepticism among medical students who are on the fence about the future of radiologists, experts in the field recently offered a detailed overview of the use of AI in imaging.

Radiographers trained to recognize certain findings on screening mammograms could help address the worldwide shortage of radiologists. 

A total of 37,073 MRI examinations conducted at 552 facilities across the U.S. between January 2010 and March 2020 were included in the analysis.